KINETISOL TECHNOLOGY: SCALE UP APPROACH

Justin Keen, AustinPx Sr. VP of Operations' talk begins with a discusion on phase-appropriate process development objectives, reviewed as they relate to scale and mode changes as product development evolves to deliver clinical trial material and develop the process design space.

Process parameter and quality attribute relationships, including those for typical pre and post KinetiSol unit operations, will be explored in the context of real-world examples.

LEARN MORE ABOUT:

• How to improve the bioavailability of poorly soluble drugs
• How to save time with KinetiSol's fusion-based, solvent free process
• The next generation of amorphous dispersion technology